SNOA
Sonoma Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$3.96M
P/E Ratio
—
EPS
$-1.95
Beta
1.76
52W High
$6.92
52W Low
$1.98
50-Day MA
$2.73
200-Day MA
$3.48
Dividend Yield
—
Profit Margin
-19.00%
Forward P/E
46.08
PEG Ratio
1.08
About Sonoma Pharmaceuticals Inc
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company is headquartered in Woodstock, Georgia.
Fundamentals
| Revenue (TTM) | $17.72M |
| Gross Profit (TTM) | $6.76M |
| EBITDA | $-2.63M |
| Operating Margin | -15.60% |
| Return on Equity | -81.20% |
| Return on Assets | -12.70% |
| Revenue/Share (TTM) | $10.72 |
| Book Value | $1.98 |
| Price-to-Book | 1.20 |
| Price-to-Sales (TTM) | 0.22 |
| EV/Revenue | 0.126 |
| EV/EBITDA | 11.46 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 22.00% |
| Shares Outstanding | $1.73M |
| Float | $1.71M |
| % Insiders | 1.17% |
| % Institutions | 6.29% |
Historical Volatility
HV 10-Day
93.79%
HV 20-Day
82.25%
HV 30-Day
78.25%
HV 60-Day
60.97%
HV Rank
—
Volatility is currently expanding
Data last updated: 4/9/2026